| Literature DB >> 20884724 |
Robert Ekblom1, Lisa French, Jon Slate, Terry Burke.
Abstract
Genes of the immune system are generally considered to evolve rapidly due to host-parasite coevolution. They are therefore of great interest in evolutionary biology and molecular ecology. In this study, we manually annotated 144 avian immune genes from the zebra finch (Taeniopygia guttata) genome and conducted evolutionary analyses of these by comparing them with their orthologs in the chicken (Gallus gallus). Genes classified as immune receptors showed elevated d(N)/d(S) ratios compared with other classes of immune genes. Immune genes in general also appear to be evolving more rapidly than other genes, as inferred from a higher d(N)/d(S) ratio compared with the rest of the genome. Furthermore, ten genes (of 27) for which sequence data were available from at least three bird species showed evidence of positive selection acting on specific codons. From transcriptome data of eight different tissues, we found evidence for expression of 106 of the studied immune genes, with primary expression of most of these in bursa, blood, and spleen. These immune-related genes showed a more tissue-specific expression pattern than other genes in the zebra finch genome. Several of the avian immune genes investigated here provide strong candidates for in-depth studies of molecular adaptation in birds.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20884724 PMCID: PMC2975445 DOI: 10.1093/gbe/evq061
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
FBox-and-whisker plot of dN/dS (ω) values between zebra finch and chicken orthologs for immune genes and whole-genome comparison (All genes). Whole-brain transcriptome comparisons (EST) between chicken and zebra finch (Axelsson et al. 2008) are also included as reference.
Genes with Data from At Least Three Bird Species that Were Identified as Targets of Positive Selection
| Gene Symbol | Number of Bird Species | χ2 | Number (and identity) of Positively Selected Sites, from PAML | Number (and identity) of Positively Selected Sites, from HyPhy | |
| 9 | 118.605 | <0.0001 | 10 (34–37, 81, 91, 94, 95, 97, 101) | 7 (36, 38, 39, 64, 83, 97, 104) | |
| 7 | 37.888 | <0.0001 | 6 (66, 79, 86, 124, 126, 165) | 4 (81, 103, 184, 366) | |
| 4 | 16.576 | 0.0003 | 3 (5, 6, 60) | 6 (83, 84, 85, 86, 98, 156) | |
| 8 | 16.666 | 0.0002 | 2 (47, 192) | 7 (50, 53, 60, 76, 77, 224, 255) | |
| 6 | 12.291 | 0.0021 | 3 (212, 388, 436) | 16 (20, 130, 230, 241, 265, 318, 345, 357, 406, 454, 486, 506, 537, 538, 539, 585) | |
| 6 | 6.974 | 0.0306 | 1 (111) | 2 (111, 159) | |
| 8 | 5.534 | 0.0629 | 0 | 8 (39, 92, 152, 169, 174, 179, 186) | |
| 3 | 3.950 | 0.139 | 0 | 3 (37, 73, 113) | |
| 3 | 1.187 | 0.552 | 0 | 11 (127, 184, 242, 245, 268, 277, 282, 285, 292, 299, 393) | |
| 3 | 0.804 | 0.669 | 0 | 8 (55, 62, 81, 166, 508, 664, 752, 760) |
Codons with a posterior probability greater than 95% for being under positive selection (calculated in PAML and HyPhy) are indicated. For plots of codon-wise ω and posterior probability of positive selection across the length of these genes, see Additional figs. 1–10.
Regression Model of ω Values for the Different Functional Categories of Immune Genes
| Category | Median ω | Model Estimate | Model Standard error | |||
| Intercept | 35.3924 | 7.5845 | 4.666 | 1.18 × 10−5*** | ||
| Receptor | 0.260 | 23 | 19.5739 | 8.198 | 2.388 | 0.0193* |
| Antigen processing | 0.236 | 12 | 10.7259 | 11.3136 | 0.948 | 0.3459 |
| Humoral response | 0.219 | 8 | 13.4626 | 13.8312 | 0.973 | 0.3332 |
| Development of immune system | 0.219 | 6 | 7.3719 | 13.4588 | 0.548 | 0.5854 |
| Involved in autoimmunity | 0.210 | 3 | 4.402 | 18.3264 | 0.24 | 0.8108 |
| Innate NK killing | 0.200 | 7 | −6.1044 | 15.3811 | −0.397 | 0.6925 |
| Expressed primarily in immune tissues | 0.200 | 25 | 12.2644 | 7.3473 | 1.669 | 0.0989† |
| Inflammation | 0.190 | 20 | 17.8269 | 11.6274 | 1.533 | 0.1291 |
| Innate immunity | 0.189 | 46 | 6.8735 | 8.7715 | 0.784 | 0.4355 |
| Adaptive immunity | 0.178 | 26 | −5.0489 | 10.6001 | −0.476 | 0.6351 |
| Related to disease | 0.177 | 24 | 0.6073 | 7.2483 | 0.084 | 0.9334 |
| Immune pathway or signaling | 0.174 | 47 | 10.2255 | 6.2947 | 1.624 | 0.1081 |
| Involved in immunodeficiencies | 0.165 | 10 | 5.6751 | 10.546 | 0.538 | 0.5919 |
| Chemotaxis | 0.157 | 16 | 2.9733 | 10.3082 | 0.288 | 0.7737 |
| Induced by immunomodulator | 0.149 | 21 | 3.8621 | 7.8428 | 0.492 | 0.6237 |
| Coagulation | 0.149 | 6 | −17.9895 | 15.0288 | −1.197 | 0.2348 |
| Phagocytosis | 0.142 | 3 | −13.6846 | 19.0216 | −0.719 | 0.4739 |
| Cellular response | 0.138 | 12 | 20.7341 | 12.8684 | 1.611 | 0.111 |
| Cytokines and chemokines | 0.122 | 38 | −12.4645 | 6.8252 | −1.826 | 0.0715† |
| Transcription factor | 0.080 | 6 | −24.2605 | 13.1965 | −1.838 | 0.0696† |
***P < 0.001; *P < 0.05; †P < 0.10.
Numbers of Immune Genes with Primary Expression in Each of the Studied Tissues
| Tissue | Number of Genes | Mean ω | Mean τ |
| Bursa | 28 | 0.28 | 0.63 |
| Blood | 28 | 0.17 | 0.60 |
| Spleen | 19 | 0.26 | 0.63 |
| Testes | 11 | 0.09 | 0.48 |
| Liver | 8 | 0.26 | 0.61 |
| Skin | 6 | 0.22 | 0.46 |
| Embryo | 5 | 0.22 | 0.53 |
| Muscle | 1 | 0.13 | — |
Mean values of ω (dN/dS ratio) and τ (index of expression specificity) for genes with primary expression in each of the tissues are also reported.
FRelationship between total expression levels and tissue specificity in expression (τ) for zebra finch immune genes.
FCorrelation between dN/dS (ω) ratios of automated and manually annotated genes. Automated dN/dS ratios were downloaded from Ensembl BioMart, whereas the manually annotated ratios were calculated in PAML4. The line represents x = y. The outlier to the right (with Manual ω = 1.51 and Ensembl ω = 0.83) is the gene for “integrin-associated protein (IAP, CD47)” and the outlier to the left (with Manual ω = 0.08 and Ensembl ω = 0.64) is the gene for interleukin 2 receptor, gamma.